Sabal Trust’s Colgate-Palmolive CL Stock Holding History

Sabal Trust’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$904K	Hold	9,650	–	–	0.05%	153
2024 Q4	$877K	Hold	9,650	–	–	0.05%	155
2024 Q3	$1M	Hold	9,650	–	–	0.05%	137
2024 Q2	$936K	Hold	9,650	–	–	0.06%	134
2024 Q1	$869K	Hold	9,650	–	–	0.05%	130
2023 Q4	$769K	Sell	9,650 -150	-2%	-$11.3K	0.05%	131
2023 Q3	$697K	Hold	9,800	–	–	0.05%	125
2023 Q2	$755K	Buy	9,800 +450	+5%	+$34.8K	0.05%	121
2023 Q1	$703K	Hold	9,350	–	–	0.05%	82
2022 Q4	$737K	Sell	9,350 -19	-0.2%	-$1.42K	0.05%	82
2022 Q3	$658K	Buy	9,369 +169	+2%	+$13.3K	0.05%	85
2022 Q2	$737K	Hold	9,200	–	–	0.05%	84
2022 Q1	$698K	Hold	9,200	–	–	0.05%	82
2021 Q4	$785K	Sell	9,200 -1,000	-10%	-$78.1K	0.05%	87
2021 Q3	$771K	Hold	10,200	–	–	0.06%	84
2021 Q2	$829K	Sell	10,200 -600	-6%	-$49.1K	0.06%	79
2021 Q1	$852K	Sell	10,800 -17	-0.2%	-$1.33K	0.06%	81
2020 Q4	$925K	Buy	10,817 +1,017	+10%	+$84.1K	0.07%	73
2020 Q3	$756K	Hold	9,800	–	–	0.07%	78
2020 Q2	$718K	Hold	9,800	–	–	0.07%	77
2020 Q1	$650K	Sell	9,800 -51	-0.5%	-$3.6K	0.07%	75
2019 Q4	$679K	Sell	9,851 -44	-0.4%	-$3K	0.05%	87
2019 Q3	$727K	Buy	9,895 +95	+1%	+$6.89K	0.06%	82
2019 Q2	$702K	Sell	9,800 -213	-2%	-$15.1K	0.06%	80
2019 Q1	$687K	Hold	10,013	–	–	0.06%	85
2018 Q4	$596K	Sell	10,013 -187	-2%	-$11.7K	0.06%	89
2018 Q3	$683K	Hold	10,200	–	–	0.06%	85
2018 Q2	$661K	Sell	10,200 -400	-4%	-$26.2K	0.06%	84
2018 Q1	$760K	Hold	10,600	–	–	0.07%	77
2017 Q4	$800K	Hold	10,600	–	–	0.08%	66
2017 Q3	$772K	Buy	10,600 +400	+4%	+$28.8K	0.08%	69
2017 Q2	$756K	Hold	10,200	–	–	0.08%	64
2017 Q1	$747K	Sell	10,200 -3,000	-23%	-$210K	0.08%	65
2016 Q4	$863K	Hold	13,200	–	–	0.09%	58
2016 Q3	$978K	Sell	13,200 -5,500	-29%	-$407K	0.11%	57
2016 Q2	$1.37M	Buy	18,700 +3,100	+20%	+$221K	0.16%	46
2016 Q1	$1.1M	Sell	15,600 -6,664	-30%	-$443K	0.13%	53
2015 Q4	$1.48M	Buy	22,264 +7,600	+52%	+$506K	0.19%	47
2015 Q3	$930K	Buy	14,664 +800	+6%	+$52.3K	0.13%	51
2015 Q2	$907K	Hold	13,864	–	–	0.12%	58
2015 Q1	$961K	Sell	13,864 -1,985	-13%	-$137K	0.13%	58
2014 Q4	$1.1M	Hold	15,849	–	–	0.14%	53
2014 Q3	$1.03M	Buy	15,849 +139	+0.9%	+$9.17K	0.14%	53
2014 Q2	$1.07M	Hold	15,710	–	–	0.15%	51
2014 Q1	$1.02M	Sell	15,710 -765	-5%	-$48.2K	0.14%	52
2013 Q4	$1.07M	Buy	16,475 +575	+4%	+$36.8K	0.15%	51
2013 Q3	$943K	Sell	15,900 -1,468	-8%	-$87K	0.15%	53
2013 Q2	$995K	Buy	+17,368	New	+$1.03M	0.16%	54

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Sabal Trust's CL Position: Q1 2025 in Review

Sabal Trust held its Colgate-Palmolive (CL) position steady in Q1 2025 at 9,650 shares worth $904K. The position accounts for 0.05% of the portfolio, ranked #153.

Sabal Trust first reported a position in CL in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.48M in Q4 2015. 1,943 funds tracked by Wall St. Rank hold CL as of Q1 2025.

Sabal Trust held 9,650 shares of Colgate-Palmolive worth $904K as of Q1 2025.
Sabal Trust left its Colgate-Palmolive share count unchanged in Q1 2025.
Colgate-Palmolive made up 0.05% of Sabal Trust's portfolio in Q1 2025, its #153 holding.
Sabal Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 48 quarters since.
Sabal Trust's Colgate-Palmolive position peaked at $1.48M in Q4 2015.
1,943 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.